Trial intelligence / Profile preview

Curcumin Capsules for Sexual Function in Postmenopausal Women

IRCT20250406065235N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in female sexual dysfunction (FSD) and sexual dysfunction, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sexual function improvement. Started Apr 2025; status: completed.

02

Drugs

curcumin
03

Conditions

female sexual dysfunction (FSD)sexual dysfunction

Beyond the preview

Go deeper on IRCT20250406065235N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250406065235N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call